Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CTRC | Q99895 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL186932 | 1.00 | ALDH1A1 (0.39) | ALDH1A1CYP3A4TSHRMAPK1TDP1 | |
| SCHEMBL206522 | 1.00 | ALDH1A1 (0.39) | ALDH1A1CYP3A4TSHRMAPK1TDP1 | |
| SCHEMBL187058 | 0.97 | CYP3A4 (0.36) | ALDH1A1CYP3A4TSHRMAPK1TDP1 | |
| SCHEMBL186892 | 0.97 | CYP3A4 (0.36) | ALDH1A1CYP3A4TSHRMAPK1TDP1 | |
| SCHEMBL786118 | 0.97 | CYP3A4 (0.36) | ALDH1A1CYP3A4TSHRMAPK1TDP1 | |
| SCHEMBL186158 | 0.91 | LMNA (0.35) | ALDH1A1TSHRL3MBTL1 | |
| SCHEMBL187471 | 0.91 | LMNA (0.35) | ALDH1A1TSHRL3MBTL1 | |
| SCHEMBL786727 | 0.91 | LMNA (0.35) | ALDH1A1TSHRL3MBTL1 | |
| SCHEMBL186960 | 0.88 | MEN1 (0.35) | ALDH1A1TSHRPOLBMBOAT4 | |
| SCHEMBL786127 | 0.88 | MEN1 (0.35) | ALDH1A1TSHRPOLBMBOAT4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785655-B2 | Ionic liquid solvents | DUBLIN CITY UNIVERSITY (IE) | 2014-07-22 | — | — | US | claimed |
| US-20120071661-A1 | Ionic Liquid Solvents | DUBLIN CITY UNIVERSITY (IE) | 2012-03-22 | — | — | US | claimed |
| EP-2401258-A1 | IONIC LIQUID SOLVENTS | Dublin City University (IE) | 2012-01-04 | — | — | EP | claimed |
| WO-2010097412-A1 | IONIC LIQUID SOLVENTS | DUBLIN CITY UNIVERSITY (IE) | 2010-09-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071661-A1 | Ionic Liquid Solvents | EBP, PAICS, HACD3 | ALDH1A1 834/4885CYP3A4 452/4885TSHR 4680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.